# Anthropic IPO: S-1 Breakdown for Indian Investors

> Anthropic's Nasdaq IPO explained from the official S-1: $70-$78 range, $33.24bn of 9M revenue, share classes, US government risk, and links for Indian investors.
- **Published**: 2026-11-10
- **Modified**: 2026-11-15
- **Category**: ipo
- **URL**: https://www.tldr.money/articles/ipo/anthropic-ipo

---

This is the **Anthropic IPO** as disclosed in the company's US offer documents: the price range, the capital being raised, the financials, the unusual share-class structure, and the risks, including a live dispute with the US government. Every figure below comes from [Amendment No. 2 to Form S-1](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm), filed with the US Securities and Exchange Commission on 10 November 2026, or from [Anthropic's roadshow announcement](https://www.anthropic.com/news/roadshow-launch) of the same day, unless another source is named.

**Last updated: 12 November 2026.** This is a **US Nasdaq** offering, ticker **ANT**, not an Indian IPO. You cannot apply for it through UPI or ASBA. For routes that may be available to Indian residents after listing, start with [How to invest in the Anthropic IPO from India](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india). What the company's own roadshow site adds is in [Official IPO site, roadshow and Q3 highlights](/articles/ipo/anthropic-ipo-official-site-roadshow-q3-results).

<div data-callout="note" data-title="Pricing week (15 November update)">

Anthropic is expected to price on 18 November and start trading on 19 November, US Eastern time: that is early morning 19 November and 8:00 pm IST on 19 November in India. The range is still $70-$78; there is no official final price yet. See [Anthropic IPO pricing week: what to watch from India](/articles/ipo/anthropic-ipo-pricing-week-what-to-watch).

</div>

> **Educational content, not investment advice.** This page explains a US initial public offering using the company's SEC filings and official sources. tldr.money is not a SEBI-registered investment adviser or research analyst, and is not a US broker-dealer. Nothing here is a recommendation to apply for, buy, sell or hold any security. US-listed shares can lose money, including on the first day of trade. The registration statement had not yet become effective as of 12 November 2026, so the shares could not yet be sold. Read the [prospectus on EDGAR](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm) and speak to a qualified adviser if you need personal advice.

<div data-callout="tldr">

- **What:** Anthropic, PBC, the San Francisco lab behind Claude, is selling **Class A common stock** to the public for the first time.
- **Price:** an expected **$70 to $78** a share.
- **Size:** **825 million** shares in the IPO, almost all new paper, plus a **$26 billion** private placement of non-voting Class N shares, plus a 30-day greenshoe of up to **123.75 million** extra shares.
- **When:** roadshow launched **10 November 2026**. The [official IPO site FAQ](https://ipo.anthropic.com/us/), checked on 12 November, says pricing is **expected** on **18 November (EST)** and the first trade on **19 November (EST)**, subject to regulatory clearance. Those dates are still expected, not a Nasdaq listing notice.
- **The catch:** a fast-growing business with heavy compute commitments, a dual-track court fight with the US government, and a voting structure in which public Class A shares do not control the company.

</div>

<div data-viz="stats" data-id="anthropic-key-facts">Price range $70-$78; 825 million IPO shares; $26 billion concurrent private placement; estimated $84.6 billion net proceeds at the $74 midpoint; expected Nasdaq listing under ANT. Source: S-1/A No. 2 and roadshow announcement, 10 Nov 2026.</div>

## What Anthropic does

Anthropic was incorporated in Delaware in January 2021 as a **public benefit corporation**. Its stated public benefit purpose, set out in its certificate of incorporation, is the responsible development and maintenance of advanced AI for the long-term benefit of humanity. The product the market knows is **Claude**, sold as models, a platform, and applications such as Claude Code and Claude Cowork.

The S-1 leans on enterprise adoption. As of 30 September 2026 the company reported more than **11,900** customers with $100,000 or more of trailing-twelve-month revenue, more than **1,900** with $1 million or more, and about **250** with $10 million or more. It states **Net Revenue Retention of about 900%** as of that date, and trailing-twelve-month revenue per employee of over **$6.6 million**. Those customer and retention figures are the company's own operating metrics; they are not GAAP line items.

Claude is also distributed through Amazon Web Services, Google Cloud and Microsoft Azure. The prospectus names systems integrators such as Accenture, Deloitte, KPMG and PwC as part of the ecosystem, and describes a services company, Ode with Anthropic, aimed at mid-sized firms.

## The offer, in numbers

<div data-viz="timeline" data-id="anthropic-ipo-timeline">S-1 filed 26 Oct 2026; Q3 figures added 2 Nov; price range and roadshow 10 Nov; official site expects pricing on 18 Nov and first trade on 19 Nov 2026 (EST), subject to regulatory clearance.</div>

The company's public roadshow room is [ipo.anthropic.com](https://ipo.anthropic.com/us/). A 12 November 2026 reading of that site, including the Q3 headlines, customer stories, US broker list and FAQ, is in [Official IPO site, roadshow and Q3 highlights](/articles/ipo/anthropic-ipo-official-site-roadshow-q3-results).

<div data-viz="stacked" data-id="anthropic-ipo-share-split">801.35 million shares from Anthropic, 23.65 million from selling stockholders, out of 825 million.</div>

<div data-callout="jargon" data-title="Primary shares, selling stockholders and a greenshoe">

**Primary shares** are new shares issued by the company; the cash goes to Anthropic. **Selling stockholders** are existing holders selling some of their stock; the company gets none of that money. A **greenshoe** is a 30-day option for the underwriters to buy extra primary shares, here up to 123.75 million, often used to help settle first-week trading. A **concurrent private placement** is a separate, unregistered sale of a different share class at the same price, closing just after the IPO.

</div>

Lead bookrunners named on the cover are **Goldman Sachs & Co. LLC** and **Morgan Stanley**. The preliminary prospectus also lists J.P. Morgan, Citigroup, Barclays, Wells Fargo Securities and a long additional syndicate. The offering includes public offers in Australia, Canada, certain EEA states, Japan, Switzerland and the United Kingdom. **India is not on that list.** Anthropic says it does not currently intend to list the Class A shares on an exchange in those other countries.

**Use of proceeds**, in the company's words: general corporate purposes, including working capital, operating expenses and capital expenditures, "including investments in compute and infrastructure," plus hiring and retention. A portion, estimated at **$3.8 billion** at the $74 midpoint and a 50.90% withholding rate, will cover tax withholding on the settlement of certain RSUs. The company may also use proceeds for acquisitions, but says it has no material acquisition commitments at this time. It has never paid a cash dividend and does not expect to in the foreseeable future.

The full rupee maths, greenshoe arithmetic and implied value on shares outstanding are on [Anthropic IPO price band, shares and timeline](/articles/ipo/anthropic-ipo-price-band-date).

## The official financials, very briefly

<div data-viz="bars" data-id="anthropic-revenue-quarterly">Quarterly revenue from Q1 2025 ($376m) to Q3 2026 ($16.96bn).</div>

For the nine months ended 30 September 2026, revenue was **$33.242 billion**, against **$2.545 billion** a year earlier. Third-quarter revenue was **$16.956 billion**, up about 1,127% from the same quarter in 2025, and up about 47% from the second quarter of 2026.

The headline **$104.039 billion** nine-month net loss is real as a GAAP number, and it is also easy to misread. **$94.324 billion** of it is a change in the fair value of convertible notes, derivative liabilities and SAFEs, which the company says was driven mainly by a higher enterprise valuation. Operating loss for the same nine months was **$1.260 billion**, narrower than the **$5.224 billion** operating loss a year earlier. Adjusted operating income, a non-GAAP measure defined in the S-1, was **$4.081 billion**, a 12% adjusted margin. Cash from operations in the same period was **$6.569 billion**. Cash and cash equivalents were **$95.6 billion**, with **$36.3 billion** of short-term investments, as of 30 September 2026.

The number that sits over the growth story is the commitment book. As of and after 30 September 2026, purchase commitments and leases total about **$900.9 billion**, substantially all for compute and infrastructure, including about **$70.7 billion** due in the following 12 months and about **$451.6 billion** expected before the end of 2030. The 2 November amendment had put the same total at about **$895.4 billion**; the 10 November filing is the later figure.

The detailed tables, charts and reconciliation notes are on [Anthropic IPO financials in the S-1](/articles/ipo/anthropic-ipo-financials-s1).

## Who actually controls the company

<div data-viz="table" data-id="anthropic-share-classes">Class A, N, T, F and E: votes, economics and holders.</div>

Public investors in this IPO will hold **Class A** shares: one vote each, and a pro-rata economic claim. That does not mean they control Anthropic.

- The company is a **Delaware public benefit corporation**. Directors must balance the pecuniary interests of stockholders, the interests of those materially affected by the company's conduct, and the stated public-benefit purpose. The S-1 warns that this balancing can conflict with short- or long-term share-price interests.
- The **Long-Term Benefit Trust**, through a single **Class T** share, generally elects and can remove a **majority of the authorised board**. Class T has no economic rights and no general vote on other stockholder matters.
- A single **Class F** share, issued at closing to a **Founder LLC** whose initial members are the seven co-founders (Dario Amodei, Daniela Amodei, Tom Brown, Jack Clark, Jared Kaplan, Sam McCandlish and Christopher Olah), is entitled to **50.1% of total voting power** on matters submitted to stockholders generally, including the election of directors other than the Class T directors. It has no economic rights.
- **Class N** shares have the same economics as Class A but **no vote**, except as required by law. They are aimed mainly at strategic partners and generally convert into Class A if sold to an unaffiliated buyer. The $26 billion concurrent placement is Class N.
- Anthropic is a **Nasdaq "controlled company"** because of the trust's board-election power, and says it expects to use that exemption only for its nominating and corporate governance committee.

The S-1 is blunt: the capital structure "may effectively eliminate the ability of holders of our Class A common stock to influence important decisions, including a change in control."

## The US government situation, in brief

This is not a side remark in the filing. It is a named risk, with its own financial-statement footnote, and the company says it "may experience **material revenue losses or business disruptions**" as a result.

According to the S-1, Anthropic's public position is that its technology should not be used for **mass domestic surveillance** or **fully autonomous weapons**. In February 2026 the President of the United States directed federal executive agencies to stop using that technology, and the US defence department -- called the **Department of War** in the filing, the name used by the current administration -- designated the company a **supply-chain risk to national security**. A California federal court, on 27 August 2026, largely granted summary judgment for Anthropic, finding the challenged actions retaliatory and in violation of the First Amendment and the Fifth Amendment's due-process clause, and, in part, the Administrative Procedure Act. The US Court of Appeals for the D.C. Circuit, in a 2-1 decision on 25 September 2026, nonetheless held that the **FASCSA Section 4713** designation was proper and that those constitutional rights were not violated. Anthropic has asked the full D.C. Circuit to rehear the case. The government has appealed the California rulings.

Separately, in June 2026 the US Department of Commerce imposed worldwide export restrictions on the **Fable 5** and **Mythos 5** models. Anthropic disabled both for all customers, then redeployed them after updating safeguards and after Commerce lifted the restrictions. The S-1 says similar controls could recur or spread to other models.

In October 2026 the US Federal Trade Commission issued a civil investigative demand about consumer protection, data protection, privacy, and product safety and security. The filing says the demand does not assert claims, and that the outcome is unpredictable.

The full timeline and a risk-style reading for a prospective shareholder are on [Anthropic IPO: the US government dispute](/articles/ipo/anthropic-ipo-trump-administration-risk).

## Other risks the S-1 puts up front

The risk-factor section runs for nearly a hundred pages. A short, non-exhaustive list of themes the company itself flags:

- Models can behave in unintended or autonomous ways, and can be misused.
- Success depends on staying at the frontier, and on securing enough compute.
- A limited number of large customers and cloud channels drive a substantial share of revenue.
- Amazon, Google and Microsoft are at once investors, cloud partners, customers and competitors.
- The regulatory and political environment for AI is evolving, including export controls.
- Historical growth rates will not necessarily repeat.
- Public Class A holders have limited influence under the governance structure.

None of that is a prediction about the stock. It is what the issuer told the SEC.

## If you are reading this from India

Treat this as a **US listing**, not as a Jio-style IPO you can bid on in a broker app. The honest questions are whether you want US-listed AI exposure at all, whether Anthropic's specific risks fit you, how you would actually buy the shares after they list, and what LRS, tax collected at source, and Indian tax on foreign shares would do to the net result. Those practical steps, with official sources for the Indian rules, are in the [invest-from-India guide](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india). A balanced list of arguments, still not a recommendation, is in [Should you invest in the Anthropic IPO?](/articles/ipo/should-you-invest-in-anthropic-ipo).

## Related reading

- [Pricing week: what to watch, in IST](/articles/ipo/anthropic-ipo-pricing-week-what-to-watch)
- [Anthropic IPO: S-1 breakdown](/articles/ipo/anthropic-ipo)
- [How to invest in the Anthropic IPO from India](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india)
- [Price range, shares and timeline](/articles/ipo/anthropic-ipo-price-band-date)
- [S-1 financials](/articles/ipo/anthropic-ipo-financials-s1)
- [The US government dispute](/articles/ipo/anthropic-ipo-trump-administration-risk)
- [Should you invest?](/articles/ipo/should-you-invest-in-anthropic-ipo)
- [IPO guides](/ipo)

## Sources

- [Anthropic, PBC, Amendment No. 2 to Form S-1, 10 November 2026](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm) (SEC EDGAR, accession 0001628280-26-072484).
- [Amendment No. 1 to Form S-1, 2 November 2026](https://www.sec.gov/Archives/edgar/data/2130357/000162828026068676/anthropicpbc-sx1ax1.htm), which first added the nine-month 2026 financials.
- [EDGAR company search for Anthropic, PBC, CIK 0002130357](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002130357&type=S-1).
- [Anthropic, "Anthropic launches roadshow for proposed initial public offering," 10 November 2026](https://www.anthropic.com/news/roadshow-launch).
- [Anthropic official IPO site (US)](https://ipo.anthropic.com/us/), checked 12 November 2026, for the Q3 headlines, participating-broker list, and the expected 18-19 November (EST) timetable in the company FAQ.
- [CNBC, "Anthropic sets price range of $70 to $78 in upcoming IPO," 10 November 2026](https://www.cnbc.com/2026/11/10/anthropic-sets-price-range-of-70-to-78-in-upcoming-ipo.html), earlier secondary reporting of the same 18-19 November window, attributed to people familiar with the plans.
---
- [More ipo articles](https://www.tldr.money/articles/category/ipo)
- [All articles](https://www.tldr.money/articles)